The First LAMA for Inhalation Using Natural Breathing

October 8, 2020 at 12:00pm Pacific (45 minutes)

The program will review the impact of COPD in the long-term care (LTC) setting, current clinical practice recommendations to improve outcomes, and a therapy option for the treatment of COPD in the LTC setting. This promotional, non-CME program presented on behalf of Sunovion Pharmaceuticals Inc., is intended only for US health care professionals involved in the treatment of patients with COPD.
Speaker:
Richard G. Stefanacci, DO, MGH, MBA, AGSF, CMD
Medical Director, Post-Acute Services & LIFE Connection/PACE
AtlantiCare/Geisinger Health System; Faculty, Thomas Jefferson University
Jefferson College of Population Health
Philadelphia, PA

Cost: FREE, Registration required.

REGISTER NOW